MNC Healthcare Company 5-Year China Strategy Planning
What We Did
SmithStreet synthesized comprehensive primary and secondary research into strategies that will keep the client ahead of the competition.
We delivered a roadmap that:
- Prioritized market segments per product
- Addressed organic and inorganic growth factors
- Proposed sales strategies per product
- Advised new product development based on market opportunities
Cancer diagnosis drives the need for sophisticated testing techniques. The true growth multiplier will stem from new product development as the government puts in place policies that address the need for reliable testing in remote areas.
Lack of doctors and pathologists will drive the development of sophisticated software that will provide accurate first readings of cell samples. This requires sharper imaging for accurate, automated computer readings, creating an opportunity to leapfrog current global trends in the sector.
Within 5 years, M&A activity with a local software company was recommended to address China specific needs that no other MNC is providing globally.
National and Provincial
MNC and domestic competitors’ SWOT
Labs, public & private hospitals by tier
Discover how SmithStreet can help your business in China